Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

284
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
284
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

242
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
242
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

300
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
300
Altered States of Awareness01:06

Altered States of Awareness

464
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
464
Drug Therapy01:28

Drug Therapy

98
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
98
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

326
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Migraine management during pregnancy, breastfeeding and in women planning pregnancy.

Cephalalgia : an international journal of headache·2025
Same author

Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2024
Same author

Adverse Childhood Experiences and Medication Overuse Headache: Burden and Treatment Impact.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2022
Same author

The Impact of Shift Work on Migraine: A Case Series and Narrative Review.

Headache·2019
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Amyloid and Tau Co-pathology in Parkinson Disease and Atypical Parkinsonism.

Current neurology and neuroscience reports·2026
Same journal

Digital Technologies for Symptom Monitoring in Parkinson Disease.

Current neurology and neuroscience reports·2026
Same journal

Effects of Mind-body Movement Interventions for Managing Symptoms in People with Multiple Sclerosis: An Overview of Reviews.

Current neurology and neuroscience reports·2026
Same journal

Effect of non-statin Therapy on the Composition and Characteristics of Carotid Atherosclerotic Plaques: A Systematic Review.

Current neurology and neuroscience reports·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K

Psychedelics and Headache Disorders: an Update.

James J H Im1,2, Claire H Sandoe3,4

  • 1Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada.

Current Neurology and Neuroscience Reports
|August 9, 2025
PubMed
Summary
This summary is machine-generated.

Psychedelics show promise for treating migraine and cluster headache at low doses, according to recent research. Further studies are needed to confirm effectiveness and safety for these headache disorders.

Keywords:
Cluster headacheDMTHeadacheLSDMigrainePsilocybinPsychedelics

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.0K

Related Experiment Videos

Last Updated: Sep 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.0K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Psychedelic compounds are being investigated for various therapeutic applications, including pain and mental health conditions.
  • Patient reports and scientific literature indicate potential benefits of psychedelics.

Purpose of the Study:

  • To review recent research on the use of psychedelic compounds for the treatment of headache disorders.
  • To assess the current evidence for psychedelic therapies in managing migraine and cluster headaches.

Main Methods:

  • Review of observational data, case reports, and small controlled trials.
  • Analysis of studies focusing on sub-hallucinogenic doses of psychedelics.

Main Results:

  • Evidence suggests symptom benefit for migraine and cluster headache at sub-hallucinogenic doses.
  • Safety profiles appear generally favorable, but concerns regarding systemic and psychiatric effects persist.
  • No new studies have been completed for other headache disorders.

Conclusions:

  • Psychedelics show potential for treating cluster headache and migraine.
  • Legal complexities and the need for further research on efficacy and safety limit current recommendations.
  • Additional controlled studies are essential to establish psychedelic therapies for headache disorders.